{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "AIRE\n",
    "[autoimmune polyendocrinopathy syndrome type I (APS1)](https://omim.org/entry/240300) is caused by homozygous, compound heterozygous, or heterozygous mutation in the autoimmune regulator gene (AIRE)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using pyphetools version 0.9.113\n"
     ]
    }
   ],
   "source": [
    "from pyphetools.creation import TemplateImporter, Moi\n",
    "from pyphetools.visualization import IndividualTable, QcVisualizer\n",
    "from IPython.display import display, HTML\n",
    "import pyphetools\n",
    "print(f\"Using pyphetools version {pyphetools.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "template = \"input/AIRE_APS1_individuals.xlsx\"\n",
    "created_by = \"0000-0002-0736-9199\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HPO version 2024-08-13\n",
      "Created encoders for 73 fields\n",
      "Importing OMIM:240300, Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, HGNC:360, AIRE,  NM_000383.4\n",
      "We output 58 GA4GH phenopackets to the directory phenopackets\n"
     ]
    }
   ],
   "source": [
    "timporter = TemplateImporter(template=template,  created_by=created_by)\n",
    "individual_list, cvalidator = timporter.import_phenopackets_from_template(leniant_MOI=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Cohort validation</h2>\n",
       "<p>Errors found with 17 of 58 phenopackets.</p>\n",
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>Error counts</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Level</th><th style=\"text-align: left;font-weight: bold;\">Error category</th><th style=\"text-align: left;font-weight: bold;\">Count</th></tr>\n",
       "<tr><td style=\"text-align: left;\">ERROR</td><td style=\"text-align: left;\">CONFLICT</td><td style=\"text-align: left;\">1</td></tr>\n",
       "<tr><td style=\"text-align: left;\">WARNING</td><td style=\"text-align: left;\">REDUNDANT</td><td style=\"text-align: left;\">29</td></tr>\n",
       "</table>\n",
       "<p>A total of 30 issues were fixed and no individual was removed from the cohort.</p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "qc = QcVisualizer(cohort_validator=cvalidator)\n",
    "display(HTML(qc.to_summary_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>58 phenopackets - PMID:16965330 (n=16); PMID:28540407 (n=1); PMID:19758376 (n=13); PMID:19807739 (n=9); PMID:22024611 (n=4); PMID:18616706 (n=15)</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Individual</th><th style=\"text-align: left;font-weight: bold;\">Disease</th><th style=\"text-align: left;font-weight: bold;\">Genotype</th><th style=\"text-align: left;font-weight: bold;\">Phenotypic features</th></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 1 (MALE; P17Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Chronic active hepatitis (HP:0200120): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 2 (MALE; P13Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Keratoconjunctivitis (HP:0001096): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 3 (FEMALE; P11Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 4 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P7Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P7Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 5 (FEMALE; P30Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y6M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y6M\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 6 (FEMALE; P36Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Keratoconjunctivitis (HP:0001096): onset ; Premature ovarian insufficiency (HP:0008209): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y6M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 7 (FEMALE; P16Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P13Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P13Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Sibling of patient 7 (MALE; P22Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 8 (FEMALE; P22Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.967_979del (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Malabsorption (HP:0002024): onset ; Chronic active hepatitis (HP:0200120): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Pancreatitis (HP:0001733): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P3Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P7Y6M))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P7Y6M\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 9 (MALE; P26Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.132+1_132+3delinsCT (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 10 (FEMALE; P23Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.769C>T (heterozygous)</li> <li>NM_000383.4:c.931del (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Keratoconjunctivitis (HP:0001096): onset ; Chronic active hepatitis (HP:0200120): onset ; Premature ovarian insufficiency (HP:0008209): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y6M))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P1Y6M\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P3Y6M))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P3Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 11 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.1A>T (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Malabsorption (HP:0002024): onset ; Chronic active hepatitis (HP:0200120): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P3Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Sibling of patient 11 (FEMALE; P31Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.1A>T (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Chronic active hepatitis (HP:0200120): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y6M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 12 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.908G>C (heterozygous)</td><td style=\"text-align: left;\">excluded: Recurrent fungal infections (HP:0002841): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P5Y6M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 13 (MALE; P20Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (heterozygous)</td><td style=\"text-align: left;\">Chronic active hepatitis (HP:0200120): onset ; Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y6M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P9Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">patient 14 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (heterozygous)</td><td style=\"text-align: left;\">excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Cataract (HP:0000518): onset <br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Recurrent fungal infections (HP:0002841): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\"> index case (MALE; P21Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.206A>C (homozygous)</td><td style=\"text-align: left;\"><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "; Hypocalcemic tetany (HP:0003472): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Diarrhea (HP:0002014): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "; Malabsorption (HP:0002024): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "; Enamel hypoplasia (HP:0006297): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "; Cataract (HP:0000518): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P19Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual III-9 (FEMALE; P14Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.1236_1239dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual III-13 (FEMALE; P17Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.1236_1239dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Nephrocalcinosis (HP:0000121): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual IV-1 (MALE; P12Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.1236_1239dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; Anti-thyroglobulin antibody positivity (HP:0032069): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "; Type I diabetes mellitus (HP:0100651): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Nephrocalcinosis (HP:0000121): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 1 individual IV-9 (MALE; P15Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.1236_1239dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; Anti-reticulin antibody positivity (HP:4000030): onset ; Anti-endomysial antibody positivity (HP:0033637): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "; Hypoparathyroidism (HP:0000829): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Iridocyclitis (HP:0001094): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Hypothyroidism (HP:0000821): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Nephrocalcinosis (HP:0000121): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "; Celiac disease (HP:0002608): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 individual V-2 (MALE; P11Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.93_94insT (homozygous)</td><td style=\"text-align: left;\">Alopecia universalis (HP:0002289): onset ; Chronic mucocutaneous candidiasis (HP:0002728): onset ; Decreased circulating parathyroid hormone level (HP:0031817): onset ; Anti-GAD65 antibody (HP:5000011): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P3Y))</b>: Type I diabetes mellitus (HP:0100651): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 individual V-3 (MALE; P2Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.93_94insT (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Chronic mucocutaneous candidiasis (HP:0002728): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y6M))</b>: Hypothyroidism (HP:0000821): onset age {\n",
       "  iso8601duration: \"P1Y6M\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 individual V-4 (FEMALE; P12Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.93_94insT (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; Anti-GAD65 antibody (HP:5000011): onset ; Anti-thyroglobulin antibody positivity (HP:0032069): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Nephrocalcinosis (HP:0000121): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Hypothyroidism (HP:0000821): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 individual V-5 (MALE; P7Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.93_94insT (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Chronic mucocutaneous candidiasis (HP:0002728): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 2 individual V-11 (MALE; P12Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.93_94insT (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10M))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P10M\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Onychomycosis (HP:0012203): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P7Y))</b>: Type I diabetes mellitus (HP:0100651): onset age {\n",
       "  iso8601duration: \"P7Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 3 individual II-5 (FEMALE; P6Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.205_208dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Chronic mucocutaneous candidiasis (HP:0002728): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 4 individual II-1 (MALE; P35Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.205_208dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003593, label=Infantile onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003593\"\n",
       "  label: \"Infantile onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Nephrocalcinosis (HP:0000121): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 5 individual II-1 (FEMALE; P10Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.1A>G (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Keratoconjunctivitis (HP:0001096): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Alopecia universalis (HP:0002289): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family 6 individual II-1 (FEMALE; P11Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.845dup (homozygous)</td><td style=\"text-align: left;\">Decreased circulating parathyroid hormone level (HP:0031817): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Iridocyclitis (HP:0001094): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Keratoconjunctivitis (HP:0001096): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Celiac disease (HP:0002608): onset ; excluded: Elevated circulating thyroid-stimulating hormone concentration (HP:0002925): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-reticulin antibody positivity (HP:4000030): onset ; excluded: Anti-endomysial antibody positivity (HP:0033637): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 1 (FEMALE; P24Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.239T>G (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P17Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P17Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 2 (FEMALE; P11Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.239T>G (homozygous)</td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P7Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P7Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 3 (FEMALE; P13Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.906T>A (homozygous)</td><td style=\"text-align: left;\">Diarrhea (HP:0002014): onset ; Nail pits (HP:0001803): onset ; Enamel hypoplasia (HP:0006297): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 4 (MALE; P23Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Cholelithiasis (HP:0001081): onset ; Nail pits (HP:0001803): onset ; Enamel hypoplasia (HP:0006297): onset ; Hypothyroidism (HP:0000821): onset ; Hypoplastic spleen (HP:0006270): onset ; Chronic sinusitis (HP:0011109): onset ; Nasal polyposis (HP:0100582): onset ; Recurrent otitis media (HP:0000403): onset ; Sepsis (HP:0100806): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; Anti-side-chain cleavage enzyme antibody positivity (HP:0034055): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P15Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P15Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P20Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P20Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 5 (MALE; P24Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.415C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Vitiligo (HP:0001045): onset ; Hypothyroidism (HP:0000821): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Chronic mucocutaneous candidiasis (HP:0002728): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset <br/><b>TimeElement(element=Age(iso8601duration=P15Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P15Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P15Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 6 (FEMALE; P4Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.967_979del (homozygous)</td><td style=\"text-align: left;\">Malabsorption (HP:0002024): onset ; Hypothyroidism (HP:0000821): onset ; Sepsis (HP:0100806): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Type I diabetes mellitus (HP:0100651): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P3Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 7 (FEMALE; P16Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.967_979del (homozygous)</td><td style=\"text-align: left;\">Antiparietal cell antibody positivity (HP:6000343): onset ; Anti-GAD65 antibody (HP:5000011): onset ; Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset <br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 8 (FEMALE; P6Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.967_979del (homozygous)</td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Chronic mucocutaneous candidiasis (HP:0002728): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypoparathyroidism (HP:0000829): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset <br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Patient 9 (FEMALE; P15Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.967_979del (homozygous)</td><td style=\"text-align: left;\">Antiparietal cell antibody positivity (HP:6000343): onset ; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nail pits (HP:0001803): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypothyroidism (HP:0000821): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Hypoplastic spleen (HP:0006270): onset ; excluded: Chronic sinusitis (HP:0011109): onset ; excluded: Nasal polyposis (HP:0100582): onset ; excluded: Recurrent otitis media (HP:0000403): onset ; excluded: Sepsis (HP:0100806): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset ; excluded: Anti-GAD65 antibody (HP:5000011): onset <br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 1 (FEMALE; P27Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.607C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia universalis (HP:0002289): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Nail dystrophy (HP:0008404): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset <br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Patchy alopecia (HP:0002232): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Hypogonadism (HP:0000135): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P24Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P24Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P25Y))</b>: Atrophic gastritis (HP:0002582): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Diarrhea (HP:0002014): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Onychomycosis (HP:0012203): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Graves disease (HP:0100647): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Anti-thyroglobulin antibody positivity (HP:0032069): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Anti-thyroid peroxidase antibody positivity (HP:0025379): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "; Anti-thyroid-stimulating hormone receptor antibody positivity (HP:0034189): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 2 (FEMALE; P36Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.607C>T (heterozygous)</li> <li>NM_000383.4:c.415C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">excluded: Alopecia universalis (HP:0002289): onset ; excluded: Patchy alopecia (HP:0002232): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Nail dystrophy (HP:0008404): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Primary adrenal insufficiency (HP:0008207): onset ; excluded: Hypogonadism (HP:0000135): onset ; excluded: Graves disease (HP:0100647): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Anti-thyroid-stimulating hormone receptor antibody positivity (HP:0034189): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 3 (MALE; P38Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.607C>T (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">excluded: Alopecia universalis (HP:0002289): onset ; excluded: Patchy alopecia (HP:0002232): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Diarrhea (HP:0002014): onset ; excluded: Onychomycosis (HP:0012203): onset ; excluded: Nail dystrophy (HP:0008404): onset ; excluded: Enamel hypoplasia (HP:0006297): onset ; excluded: Hypogonadism (HP:0000135): onset ; excluded: Graves disease (HP:0100647): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Anti-thyroid-stimulating hormone receptor antibody positivity (HP:0034189): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P15Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P15Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P25Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P25Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 4 (FEMALE; P32Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.607C>T (homozygous)</td><td style=\"text-align: left;\">Diarrhea (HP:0002014): onset ; Onychomycosis (HP:0012203): onset ; Anti-21-hydroxylase antibody positivity (HP:0034071): onset ; excluded: Alopecia universalis (HP:0002289): onset ; excluded: Patchy alopecia (HP:0002232): onset ; excluded: Nail dystrophy (HP:0008404): onset ; excluded: Graves disease (HP:0100647): onset ; excluded: Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Anti-thyroglobulin antibody positivity (HP:0032069): onset ; excluded: Anti-thyroid peroxidase antibody positivity (HP:0025379): onset ; excluded: Anti-thyroid-stimulating hormone receptor antibody positivity (HP:0034189): onset <br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Vitiligo (HP:0001045): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "; Enamel hypoplasia (HP:0006297): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Hypogonadism (HP:0000135): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P22Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P22Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P27Y))</b>: Atrophic gastritis (HP:0002582): onset age {\n",
       "  iso8601duration: \"P27Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 1 (MALE; P15Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Vitiligo (HP:0001045): onset ; Atrophic gastritis (HP:0002582): onset ; Malabsorption (HP:0002024): onset ; Type I diabetes mellitus (HP:0100651): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 3 (MALE; P32Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Vitiligo (HP:0001045): onset ; Malabsorption (HP:0002024): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 4 (MALE; P17Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P3Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P3Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 6 (FEMALE; P58Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Graves disease (HP:0100647): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset <br/><b>TimeElement(element=Age(iso8601duration=P7Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P7Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P19Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 7 (FEMALE; P33Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Graves disease (HP:0100647): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset <br/><b>TimeElement(element=Age(iso8601duration=P2Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P2Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 13 (FEMALE; P13Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Atrophic gastritis (HP:0002582): onset ; Seizure (HP:0001250): onset ; Type I diabetes mellitus (HP:0100651): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset ; excluded: Premature ovarian insufficiency (HP:0008209): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 15 (MALE; P36Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P9Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P9Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P14Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P14Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 17 (MALE; P8Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.769C>T (homozygous)</td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 18 (MALE; P43Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.232T>C (homozygous)</td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P6Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P6Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P19Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P19Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 19 (MALE; P21Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.232T>C (heterozygous)</li> <li>NM_000383.4:c.1072C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P5Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P5Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 20 (MALE; P16Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.232T>C (heterozygous)</li> <li>NM_000383.4:c.1072C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P8Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "; Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P8Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 21 (MALE; P21Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.232T>C (heterozygous)</li> <li>NM_000383.4:c.1072C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Alopecia (HP:0001596): onset ; Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=OntologyClass(id=HP:0003623, label=Neonatal onset))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset ontology_class {\n",
       "  id: \"HP:0003623\"\n",
       "  label: \"Neonatal onset\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P13Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P13Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 22 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\">NM_000383.4:c.607C>T (homozygous)</td><td style=\"text-align: left;\">Vitiligo (HP:0001045): onset ; Seizure (HP:0001250): onset ; Nephrocalcinosis (HP:0000121): onset ; Premature ovarian insufficiency (HP:0008209): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P10Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P10Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P22Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P22Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 23 (MALE; P18Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.607C>T (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Malabsorption (HP:0002024): onset ; Antiparietal cell antibody positivity (HP:6000343): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Vitiligo (HP:0001045): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Atrophic gastritis (HP:0002582): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P4Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P4Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P17Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P17Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Case 24 (MALE; P15Y)</td><td style=\"text-align: left;\">Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)</td><td style=\"text-align: left;\"><ul> <li>NM_000383.4:c.607C>T (heterozygous)</li> <li>NM_000383.4:c.769C>T (heterozygous)</li> </ul></td><td style=\"text-align: left;\">Vitiligo (HP:0001045): onset ; Atrophic gastritis (HP:0002582): onset ; excluded: Alopecia (HP:0001596): onset ; excluded: Cholelithiasis (HP:0001081): onset ; excluded: Seizure (HP:0001250): onset ; excluded: Malabsorption (HP:0002024): onset ; excluded: Nephrocalcinosis (HP:0000121): onset ; excluded: Type I diabetes mellitus (HP:0100651): onset ; excluded: Asplenia (HP:0001746): onset ; excluded: Graves disease (HP:0100647): onset <br/><b>TimeElement(element=Age(iso8601duration=P1Y))</b>: Chronic mucocutaneous candidiasis (HP:0002728): onset age {\n",
       "  iso8601duration: \"P1Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P11Y))</b>: Hypoparathyroidism (HP:0000829): onset age {\n",
       "  iso8601duration: \"P11Y\"\n",
       "}\n",
       "<br/><b>TimeElement(element=Age(iso8601duration=P12Y))</b>: Primary adrenal insufficiency (HP:0008207): onset age {\n",
       "  iso8601duration: \"P12Y\"\n",
       "}\n",
       "</td></tr>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table = IndividualTable(cvalidator.get_error_free_individual_list())\n",
    "display(HTML(table.to_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[pyphetools] Ingested 58 GA4GH phenopackets.\n",
      "\tAutoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300): n=58\n",
      "We found a total of 47 unique HPO terms\n",
      "Extracted disease: Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia (OMIM:240300)\n",
      "Wrote HPOA disease file to OMIM-240300.tab\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>#diseaseID</th>\n",
       "      <th>diseaseName</th>\n",
       "      <th>phenotypeID</th>\n",
       "      <th>phenotypeName</th>\n",
       "      <th>onsetID</th>\n",
       "      <th>onsetName</th>\n",
       "      <th>frequency</th>\n",
       "      <th>sex</th>\n",
       "      <th>negation</th>\n",
       "      <th>modifier</th>\n",
       "      <th>description</th>\n",
       "      <th>publication</th>\n",
       "      <th>evidence</th>\n",
       "      <th>biocuration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OMIM:240300</td>\n",
       "      <td>Autoimmune polyendocrinopathy syndrome , type ...</td>\n",
       "      <td>HP:0000829</td>\n",
       "      <td>Hypoparathyroidism</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>8/9</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:19807739</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-11-20]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>OMIM:240300</td>\n",
       "      <td>Autoimmune polyendocrinopathy syndrome , type ...</td>\n",
       "      <td>HP:0008207</td>\n",
       "      <td>Primary adrenal insufficiency</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>7/9</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:19807739</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-11-20]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>OMIM:240300</td>\n",
       "      <td>Autoimmune polyendocrinopathy syndrome , type ...</td>\n",
       "      <td>HP:0001596</td>\n",
       "      <td>Alopecia</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>2/9</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:19807739</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-11-20]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>OMIM:240300</td>\n",
       "      <td>Autoimmune polyendocrinopathy syndrome , type ...</td>\n",
       "      <td>HP:0001045</td>\n",
       "      <td>Vitiligo</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>1/9</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:19807739</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-11-20]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>OMIM:240300</td>\n",
       "      <td>Autoimmune polyendocrinopathy syndrome , type ...</td>\n",
       "      <td>HP:0000821</td>\n",
       "      <td>Hypothyroidism</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>3/9</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>PMID:19807739</td>\n",
       "      <td>PCS</td>\n",
       "      <td>ORCID:0000-0002-0736-9199[2024-11-20]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    #diseaseID                                        diseaseName phenotypeID  \\\n",
       "0  OMIM:240300  Autoimmune polyendocrinopathy syndrome , type ...  HP:0000829   \n",
       "1  OMIM:240300  Autoimmune polyendocrinopathy syndrome , type ...  HP:0008207   \n",
       "2  OMIM:240300  Autoimmune polyendocrinopathy syndrome , type ...  HP:0001596   \n",
       "3  OMIM:240300  Autoimmune polyendocrinopathy syndrome , type ...  HP:0001045   \n",
       "4  OMIM:240300  Autoimmune polyendocrinopathy syndrome , type ...  HP:0000821   \n",
       "\n",
       "                   phenotypeName onsetID onsetName frequency sex negation  \\\n",
       "0             Hypoparathyroidism                         8/9                \n",
       "1  Primary adrenal insufficiency                         7/9                \n",
       "2                       Alopecia                         2/9                \n",
       "3                       Vitiligo                         1/9                \n",
       "4                 Hypothyroidism                         3/9                \n",
       "\n",
       "  modifier description    publication evidence  \\\n",
       "0                       PMID:19807739      PCS   \n",
       "1                       PMID:19807739      PCS   \n",
       "2                       PMID:19807739      PCS   \n",
       "3                       PMID:19807739      PCS   \n",
       "4                       PMID:19807739      PCS   \n",
       "\n",
       "                             biocuration  \n",
       "0  ORCID:0000-0002-0736-9199[2024-11-20]  \n",
       "1  ORCID:0000-0002-0736-9199[2024-11-20]  \n",
       "2  ORCID:0000-0002-0736-9199[2024-11-20]  \n",
       "3  ORCID:0000-0002-0736-9199[2024-11-20]  \n",
       "4  ORCID:0000-0002-0736-9199[2024-11-20]  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmid = \"PMID:36333996\"\n",
    "df = timporter.create_hpoa_from_phenopackets(pmid=pmid, mode_of_inheritance=Moi.AR)\n",
    "df.head()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ps24venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
